Primary liver cancer and advanced hepatobiliary malignancies represent a growing global health challenge, driven by chronic liver disease, viral hepatitis, and metabolic disorders. Early detection remains difficult, and many patients present with advanced disease. Advances in imaging, molecular profiling, and staging systems have improved diagnostic accuracy and treatment planning. Therapeutic options now include locoregional therapies, systemic targeted agents, immunotherapy, and combination approaches. Multidisciplinary care involving hepatology, oncology, surgery, and interventional radiology is essential for optimal management. Ongoing research focuses on identifying predictive biomarkers, overcoming treatment resistance, and improving survival in advanced disease. This topic explores evolving strategies in hepatobiliary oncology, emphasizing precision medicine and integrated care models.
Title : Gastroenterology viewed through a glass darkly an IDI perspective
Gilles R G Monif, University of Florida and Infectious Diseases Incorporated, United States
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena Hospital, Italy
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil